2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity

Author:

Sulkowski Parker L.12,Corso Christopher D.1,Robinson Nathaniel D.1,Scanlon Susan E.13,Purshouse Karin R.1,Bai Hanwen2,Liu Yanfeng1,Sundaram Ranjini K.1,Hegan Denise C.1,Fons Nathan R.13,Breuer Gregory A.13,Song Yuanbin4,Mishra-Gorur Ketu5,De Feyter Henk M.6,de Graaf Robin A.6,Surovtseva Yulia V.7,Kachman Maureen8,Halene Stephanie4,Günel Murat25,Glazer Peter M.12,Bindra Ranjit S.13

Affiliation:

1. Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA.

2. Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.

3. Department of Experimental Pathology, Yale University School of Medicine, New Haven, CT 06520, USA.

4. Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.

5. Department of Neurosurgery, Yale University School of Medicine, New Haven, CT 06520, USA.

6. Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT 06520, USA.

7. Yale Center for Molecular Discovery, West Haven, CT 06516, USA.

8. Michigan Regional Comprehensive Metabolomics Resource Core, National Institute of Environmental Health Sciences (NIEHS) Children’s Health Exposure Analysis Resource for Metabolomics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Abstract

The oncometabolite 2-hydroxyglutarate renders IDH1/2 mutant cancer cells deficient in homologous recombination and confers vulnerability to synthetic lethal targeting with PARP inhibitors.

Funder

NIH

American Cancer Society

Connecticut Department of Public Health

NIH Medical Scientist Program Training

NIH National Institute of General Medical Sciences

NIH Common Funds

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Cited by 444 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3